Ophthalmology therapeutic - Alchemedicine/Senju Pharmaceutical
Latest Information Update: 09 Oct 2023
At a glance
- Originator Alchemedicine; Senju Pharmaceutical
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Eye disorders